FibroGen, Inc.
FGEN
$8.12
$0.040.50%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -20.18% | -50.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -20.18% | -50.78% | |||
| Cost of Revenue | -80.66% | -36.88% | |||
| Gross Profit | 98.37% | 31.19% | |||
| SG&A Expenses | -24.97% | -12.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -50.44% | -25.81% | |||
| Operating Income | 53.94% | 21.19% | |||
| Income Before Tax | 4.57% | 17.83% | |||
| Income Tax Expenses | -- | -4,700.00% | |||
| Earnings from Continuing Operations | 3.92% | 18.39% | |||
| Earnings from Discontinued Operations | 3,416.15% | -71.60% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2,738.91% | -263.89% | |||
| EBIT | 53.94% | 21.19% | |||
| EBITDA | 54.73% | 20.94% | |||
| EPS Basic | 2,737.60% | -263.74% | |||
| Normalized Basic EPS | 51.29% | 19.65% | |||
| EPS Diluted | 2,737.60% | -263.74% | |||
| Normalized Diluted EPS | 51.29% | 19.65% | |||
| Average Basic Shares Outstanding | 0.05% | 0.09% | |||
| Average Diluted Shares Outstanding | 0.05% | 0.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||